Perkins Coie Trust Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,650
Closed -$878K 245
2025
Q4
$878K Hold
8,650
0.16% 64
2025
Q3
$473K Hold
8,650
0.09% 74
2025
Q2
$460K Hold
8,650
0.08% 82
2025
Q1
$374K Hold
8,650
0.08% 85
2024
Q4
$486K Hold
8,650
0.11% 79
2024
Q3
$589K Hold
8,650
0.13% 79
2024
Q2
$365K Hold
8,650
0.09% 80
2024
Q1
$597K Hold
8,650
0.14% 78
2023
Q4
$640K Sell
8,650
-6
-0.1% -$393 0.16% 71
2023
Q3
$591K Buy
8,656
+6
+0.1% +$509 0.17% 70
2023
Q2
$812K Hold
8,650
0.23% 64
2023
Q1
$587K Hold
8,650
0.18% 63
2022
Q4
$428K Hold
8,650
0.14% 69
2022
Q3
$281K Hold
8,650
0.11% 72
2022
Q2
$341K Hold
8,650
0.12% 73
2022
Q1
$605K Hold
8,650
0.19% 62
2021
Q4
$673K Hold
8,650
0.2% 62
2021
Q3
$826K Hold
8,650
0.26% 65
2021
Q2
$1.07M Hold
8,650
0.33% 61
2021
Q1
$1.14M Hold
8,650
0.38% 60
2020
Q4
$1.15M Buy
8,650
+500
+6% +$60.5K 0.39% 61
2020
Q3
$831K Hold
8,150
0.33% 62
2020
Q2
$709K Hold
8,150
0.29% 65
2020
Q1
$473K Hold
8,150
0.24% 77
2019
Q4
$754K Buy
+8,150
New +$717K 0.31% 66

Other funds holding EXAS

Perkins Coie Trust Company's EXAS Position: Q1 2026 in Review

Perkins Coie Trust Company sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 8,650 shares — an estimated $878K sold.

Perkins Coie Trust Company first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $1.15M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Perkins Coie Trust Company reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Perkins Coie Trust Company sold 8,650 Exact Sciences shares in Q1 2026, an estimated $878K.
  • Perkins Coie Trust Company first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
  • Perkins Coie Trust Company's Exact Sciences position peaked at $1.15M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Perkins Coie Trust Company's 13F filing for Q1 2026, filed 15 Apr 2026.